CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2024		102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	$ 1,418,150	$ (65,138)	$ 24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,350				17,350
Other comprehensive income (loss)	11,472			11,472
Dividends declared	(60,163)		(60,163)
Net issuances of restricted stock (in shares)		823,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,705		16,705
Repurchases of common stock (in shares)		(858,000)
Repurchases of common stock	(50,145)	$ (1)	(7,905)		(42,239)
Balance at ending of period (in shares) at Mar. 31, 2025		102,164,000
Balance at end of period at Mar. 31, 2025	$ 1,313,222	$ 102	1,366,786	(53,666)	0
Balance at beginning of period (in shares) at Dec. 31, 2025	101,140,684	101,141,000
Balance at beginning of period at Dec. 31, 2025	$ 1,275,857	$ 101	1,304,939	(29,183)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,790				13,790
Other comprehensive income (loss)	(4,018)			(4,018)
Dividends declared	(59,647)		(51,867)		(7,780)
Net issuances of restricted stock (in shares)		1,402,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	11,259		11,259
Repurchases of common stock (in shares)		(249,000)
Repurchases of common stock	$ (6,010)				(6,010)
Balance at ending of period (in shares) at Mar. 31, 2026	102,293,590	102,294,000
Balance at end of period at Mar. 31, 2026	$ 1,231,231	$ 102	$ 1,264,330	$ (33,201)	$ 0